Community-associated Clostridium difficile infection: How real is it?

Anaerobe

Volumn 24, Issue , 2013, Pages 121-123

  Lessa, Fernanda C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Clostridium difficile infection; Community associated; Surveillance

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MALE; MIDDLE AGED; MIXED INFECTION; MOLECULAR DIAGNOSIS; MORTALITY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; UNITED STATES;

CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY-ASSOCIATED; SURVEILLANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84889085427     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.01.006     Document Type: Article

References (26)

1. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., et al. Alarge outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273-280.
2. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. NEngl J Med 2005, 353:2433-2441.
3. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., et al. Apredominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. NEngl J Med 2005, 353:2442-2449.
4. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Statistical brief #124. [accessed 28.08.2012]. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf.
5. McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006, 12:409-415.
6. Miller B.A., Chen L.F., Sexton D.J., Anderson D.J. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011, 32:387-390.
7. Centers for Disease Control and Prevention (CDC) Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005, 54:1201-1205.
8. Measuring the scope of Clostridium difficile infection in the United States. [accessed 28.08.2012]. http://www.cdc.gov/hai/eip/cdiff_techinfo.html.
9. Kutty P.K., Woods C.W., Sena A.C., Benoit S.R., Naggie S., Frederick J., et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010, 16:197-204.
10. Lambert P.J., Dyck M., Thompson L.H., Hammond G.W. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol 2009 Oct, 30(10):945-951.
11. Wilcox M.H., Mooney L., Bendall R., Settle C.D., Fawley W.N. Acase-control study of community-associated Clostridium difficile infection. JAntimicrob Chemother 2008, 62:388-396.
12. Norén T., Akerlund T., Bäck E., Sjöberg L., Persson I., Alriksson I., et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. JClin Microbiol 2004, 42:3635-3643.
13. [accessed 28.08.2012]. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/default.htm.
14. Deshpande A., Pasupuleti V., Rolston D.D., Jain A., Deshpande N., Pant C., et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011 Oct, 53(7):e81-e90.
15. Eyre D.W., Walker S., Wyllie D., Dingle K.E., Griffiths D., Finney J., et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012 Aug, 55(Suppl. 2):S77-S87.
16. Hensgens M.P., Goorhuis A., Dekkers O.M., Kuijper E.J. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. JAntimicrob Chemother 2012, 67:742-748.
17. Dumyati G., Stevens V., Hannett G.E., Thompson A.D., Long C., Maccannell D., et al. Community-associated Clostridium difficile infections, Monroe county, New York, USA. Emerg Infect Dis 2012 Mar, 18(3):392-400.
18. Dial S., Delaney J.A., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAm Med Assoc 2005 Dec 21, 294(23):2989-2995.
19. Deshpande A., Pant C., Pasupuleti V., Rolston D.D., Jain A., Deshpande N., et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol 2012, 10:225-233.
20. Harvey R.B., Norman K.N., Andrews K., Norby B., Hume M.E., Scanlan C.M., et al. Clostridium difficile in retail meat and processing in Texas. JVet Diagn Invest 2011, 23:807-811.
21. Songer J.G., Trinh H.T., Killgore G.E., Thompson A.D., McDonald L.C., Limbago B.M. Clostridium difficile in retail meat products, USA. Emerg Infect Dis 2007, 2009(15):819-821.
22. Weese J.S. Clostridium difficile in food-innocent bystander or serious threat?. Clin Microbiol Infect 2010, 16:3-10.
23. Limbago B., Thompson A.D., Greene S.A., MacCannell D., MacGowan C.E., Jolbitado B., et al. Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats. Food Microbiol 2012, 32:448-451.
24. Jury L.A., Kundrapu S., Cadnum J., Sitzlar B.M., Donskey C.J. Do patients with recent Clostridium difficile infection present a significant risk for transmission in the outpatient clinic setting. Presented at the interscience conference on antimicrobial agents and chemotherapy September 17, 2011, Abstract#220.
25. Matsuki S., Ozaki E., Shozu M., Inoue M., Shimizu S., Yamaguchi N., et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 2005, 8:43-48.
26. Pépin J., Gonzales M., Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. JInfect 2012, 64:387-390.